InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Stahler Rachel A, Directeur Exécutif. Officer active across 2 companies, notably Neogenomics INC. In total, 6 filings have been logged. The latest transaction was disclosed on 10 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
015,556 shares0
Common Stock
SEC:0001077183-22-000109:0·
3,046 shares
Common Stock
SEC:0001104659-22-056632:0·
€311,80212,890 shares@ €24.18950.0089% mcap100.0% of flow
Common Stock
SEC:0000899243-21-032180·
€311,80212,890 shares@ €24.18950.0089% mcap50.0% of flow
Common Stock
SEC:0000899243-21-032180:0·
03,081 shares0
Common Stock
SEC:0001077183-21-000159·
03,081 shares0
Common Stock
SEC:0001077183-21-000159:0·
6 of 6 declarations
About Stahler Rachel A
Rachel A. Stahler is a Board Member and Chief Information Officer at Neogenomics Inc and Organon & Co. She is responsible for managing information systems and developing technology strategies. Her expertise in information technology management is essential for supporting the company's growth.
